Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
Friday, May 15, 2026 1 min read
Key Takeaway: CorMedix Therapeutics has announced its participation in the RBC Capital Markets Global Healthcare Conference and the Jefferies Global Healthcare Conference, both hosted in New York. The events will allow the company's management to engage in discussions through fireside chats and investor meetings. These conferences are set for May 19-20 and June 2-4, 2026, respectively, providing a platform for CorMedix to showcase its commitment to developing therapeutic products for severe medical conditions.
Conference Participation Details
Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
Archived versions will be available following the live events for a limited time.
Market Sentiment Analysis
POSITIVE FACTORS
Participation in major healthcare conferences enhances visibility.
Opportunities for networking with investors and stakeholders.
Focus on life-threatening conditions showcases strong therapeutic intent.
Full Press Release Details
PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:
RBC Capital Markets Global Healthcare Conference
Date:
Wednesday, May 20, 2026
Time:
11:00am EDT
Webcast:
Click here
Jefferies Global Healthcare Conference
Date:
Wednesday, June 3, 2026
Time:
4:20pm EDT
Webcast:
Click here
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit: www.cormedix.com.